Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury - Wikidata - wikimedia - TriplyDB

Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury

Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury

http://www.wikidata.org/entity/Q28566123

about

Receptor for advanced glycation end products and its involvement in inflammatory diseases Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis Biomarkers in Pediatric ARDS: Future Directions A Pathophysiologic Approach to Biomarkers in Acute Respiratory Distress Syndrome Acute respiratory distress syndrome following cardiovascular surgery: current concepts and novel therapeutic approaches Biomarkers of lung injury in cardiothoracic surgery The HMGB1-RAGE Inflammatory Pathway: Implications for Brain Injury-Induced Pulmonary Dysfunction The role of the receptor for advanced glycation end-products in a murine model of silicosis Using a non-invasive assessment of lung injury in a murine model of acute lung injury Systemic biomarkers of neutrophilic inflammation, tissue injury and repair in COPD patients with differing levels of disease severity Receptor for advanced glycation end products is detrimental during influenza A virus pneumonia.Receptor for advanced glycation end products (RAGE) on iNKT cells mediates lung ischemia-reperfusion injury.Acute hyperglycemic exacerbation of lung ischemia-reperfusion injury is mediated by receptor for advanced glycation end-products signaling.Plasma CC16 levels are associated with development of ALI/ARDS in patients with ventilator-associated pneumonia: a retrospective observational study.Prediction of non-recovery from ventilator-demanding acute respiratory failure, ARDS and death using lung damage biomarkers: data from a 1200-patient critical care randomized trial.Plasma levels of surfactant protein D and KL-6 for evaluation of lung injury in critically ill mechanically ventilated patients.Molecular Mechanisms of Mild and Severe Pneumonia: Insights from RNA Sequencing The receptor for advanced glycation end products (RAGE) and the lung.Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) prevents lipopolysaccharide (LPS)-induced, sepsis-related severe acute lung injury in mice.Biomarkers of lung epithelial injury and inflammation distinguish severe sepsis patients with acute respiratory distress syndrome.Defining and predicting severe community-acquired pneumonia.The biological effects of higher and lower positive end-expiratory pressure in pulmonary and extrapulmonary acute lung injury with intra-abdominal hypertension Lack of the receptor for advanced glycation end-products attenuates E. coli pneumonia in mice Short-term glutamine supplementation decreases lung inflammation and the receptor for advanced glycation end-products expression in direct acute lung injury in mice.Contribution of damage-associated molecular patterns to transfusion-related acute lung injury in cardiac surgery.Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis.Endocan levels in peripheral blood predict outcomes of acute respiratory distress syndrome The association of plasma biomarkers with computed tomography-assessed emphysema phenotypes.AGER -429T/C is associated with an increased lung disease severity in cystic fibrosis Heterogeneous phenotypes of acute respiratory distress syndrome after major trauma.The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease?Role of endothelin-1 in acute lung injury.Plasma levels of sRAGE, loss of aeration and weaning failure in ICU patients: a prospective observational multicenter study Proteolytic release of the receptor for advanced glycation end products from in vitro and in situ alveolar epithelial cells.Soluble isoform of the receptor for advanced glycation end products as a biomarker for postoperative respiratory failure after cardiac surgery C-peptide, a novel inhibitor of lung inflammation following hemorrhagic shock Plasma levels of soluble receptor for advanced glycation end products in patients with acute respiratory distress syndrome Soluble receptor for advanced glycation end products as an indicator of pulmonary vascular injury after cardiac surgery Acute lung injury: epidemiology, pathogenesis, and treatment.Biomarkers in acute lung injury--marking forward progress.

P2860

Q21285070-D53B816B-165A-433C-8891-1C30E2B28746 Q24645989-D79C457D-9BD6-4D75-B57E-B5FCF4A88808 Q26744577-D639134F-6E62-4FCD-BD6C-AA5B5295866C Q26765351-B25880A2-F308-4691-83ED-385E208DD1DE Q27693319-450E55C8-58C9-432B-AF31-7E5A9AD1F283 Q28080960-031F1904-4B8C-4AA9-8D2E-1F7EDED1FE16 Q28085089-F3A57562-50C7-46F7-922F-8B16BEC01AF4 Q28394344-477AEE3D-E76B-46F1-8864-25E6C715D1B4 Q28654276-C5248248-F0FA-4C1B-A464-D69087FB01DF Q28728578-912652F5-7469-46F1-A240-ED20DCD04E2D Q30378823-D6EF0822-0873-444F-9F1E-5C7FF3D4C3CC Q30410928-ED312B4F-501E-4109-9F70-DA10C82F3ED9 Q30422075-653BA652-F2DF-4CA6-ACCA-C06C4D5904C9 Q30951627-19AED09F-8AF0-4126-B145-BDC3A62B14FC Q31143915-D9715A3E-52C5-4A2B-A283-D7CBF5851BDB Q33531552-C44744E4-FFCD-4B0B-9E25-4A291A858ED9 Q33561786-1D5F0A26-F15B-4EB8-98B7-C4724D51E61D Q33633330-0D8AE65A-98B5-4B7D-995C-EAC55AFF2BA2 Q33718932-24C79AF8-BDBE-401D-B252-0B29E15D4849 Q33750995-740C4D06-4D74-45B1-B2CA-AF49C0E64917 Q33872274-88D33FC9-33EB-4EB8-BCC4-EE4EFEBD1267 Q33892447-86F9805B-A9D8-450E-87B4-460311248CD7 Q33918403-D4A03CEB-4C57-4A5D-A59B-141FE8FF1185 Q33945173-DF046A57-78B5-4A1A-B1AA-4215E6C0DB38 Q33953460-D1119913-F6E3-4C09-B6AF-1B847B10FBC6 Q33994636-DF9CFFAA-054D-4E19-AA11-107E5A414419 Q34012386-593CEA87-17D4-449E-B3CD-A405D9CCB44A Q34346490-7F3F991D-21E0-4508-BF6C-A41A1521A5DE Q34364298-2F05651C-177F-414D-B970-7D2FA4C69F3F Q34479261-8110CD44-4335-4BF8-A9FC-9DE1CD172DFE Q34561697-2427955B-D219-4281-89F1-12C0C7132A80 Q34615080-BF045D4E-DD4B-4204-9AB8-20165DCAD57F Q34749439-C6FD1D42-35AB-43CD-A690-A5D20307B641 Q34784921-67E1EBCD-D656-40AC-93B9-8DAA5E12584A Q34875734-62824533-A414-4AF2-849D-AE1C20C4BB90 Q34979560-1ED50809-5E5E-4397-94D8-B87628F9A978 Q35017280-5365C8DD-59D0-4985-8659-954C876CD271 Q35068413-7902BB6A-B53E-41AC-A303-BD08F0282759 Q35097126-EB83568D-8BE5-4415-88D3-E0222EB15921 Q35100674-8096A20C-FC41-4D1F-9883-302525A0EAC1

P2860

Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury

http://www.wikidata.org/entity/Q28566123

description

2006 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մայիսին հրատարակված գիտական հոդված

@hy

artículu científicu espublizáu en 2006

@ast

im Mai 2006 veröffentlichter wissenschaftlicher Artikel

@de

scientific journal article

@en

vedecký článok (publikovaný 2006/05/01)

@sk

vědecký článek publikovaný v roce 2006

@cs

wetenschappelijk artikel (gepubliceerd op 2006/05/01)

@nl

наукова стаття, опублікована в травні 2006

@uk

مقالة علمية (نشرت في مايو 2006)

@ar

name

Receptor for advanced glycatio ...... ll injury in acute lung injury

@ast

Receptor for advanced glycatio ...... ll injury in acute lung injury

@en

Receptor for advanced glycatio ...... ll injury in acute lung injury

@nl

type

label

Receptor for advanced glycatio ...... ll injury in acute lung injury

@ast

Receptor for advanced glycatio ...... ll injury in acute lung injury

@en

Receptor for advanced glycatio ...... ll injury in acute lung injury

@nl

prefLabel

Receptor for advanced glycatio ...... ll injury in acute lung injury

@ast

Receptor for advanced glycatio ...... ll injury in acute lung injury

@en

Receptor for advanced glycatio ...... ll injury in acute lung injury

@nl

P1433

Q28566123-19BDA1C1-F31F-46EA-AD3E-127FCC9B7E1F

P1476

Q28566123-EF405985-0CA9-45D9-A85C-DF1239B68533

P2093

Q28566123-423ABDFD-E6E6-4902-B64E-F5FC5F4422CE

Q28566123-5EAD46D6-B811-4409-9325-9D4840674276

Q28566123-775FBA05-6D41-471A-90F2-F42D3C1DDD96

Q28566123-92FFD386-F8A8-4F55-9E7F-951F8A1CEF8B

Q28566123-AD1C0AC2-5D02-4426-B5E9-9A5636A566D4

Q28566123-CA384563-F3F2-4F76-8E0B-92A30B3E869E

Q28566123-F88B2E11-BB4D-4945-8855-00F13E06598D

P2860

Q28566123-0E296846-0776-4DF2-9226-9FB29EC59B37

Q28566123-113AE0DB-003E-49A6-9B8F-76F1AA5745C6

Q28566123-14713CDB-C59D-4A46-8384-EBB744863E86

Q28566123-163AC300-4B88-4EDB-9A34-411F694FD0F0

Q28566123-19D95E5B-B6F4-4CE8-87E4-C966B3BC70F5

Q28566123-27B1BEAF-58C1-4A75-A0F0-B428249F1819

Q28566123-34DB1C38-9BC7-403D-8F82-796B6BE07832

Q28566123-37615615-4CE6-4BD9-84E0-43B599D32D70

Q28566123-3B0A58FF-6BA3-44DD-BF79-59FB34451552

Q28566123-3BF07A86-1FE7-4445-AC3E-D55102DD31EF

P304

Q28566123-ECB18BE8-431F-4605-A4DD-A4FD33C78E85

P31

Q28566123-6BD08757-749D-4834-8F52-2EEB01DDF808

P3181

Q28566123-7CEAA7F4-EC9B-4057-A01A-D23B358A67A6

P356

Q28566123-63DD1AF3-A2C3-419A-B6F6-4874CE6EDCA0

P407

Q28566123-0B7894E6-C15C-476E-B14A-04E9D1DAA76F

P433

Q28566123-323C44FB-85BC-4695-8FB0-F4697B11DAA1

P478

Q28566123-712254C6-CA47-4E76-8CA2-118E2FBA85A5

P50

Q28566123-D2E9F7DA-BCBC-45E3-A224-9FAB0BB13C2F

Q28566123-D655AC82-5828-4023-B1FC-4E029DE341E4

P577

Q28566123-22EFC1F6-C0CD-44AE-8AEE-4A69B02C3BC5

P698

Q28566123-C95AB92E-F80A-4D20-9908-EA95E95F46BB

P932

Q28566123-3D421629-2A0F-4E81-9349-6DF961E28596

P3181

P356

RCCM.200509-1477OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Receptor for advanced glycatio ...... ll injury in acute lung injury

@en

P2093

Gabe Mednick

http://www.w3.org/2001/XMLSchema#string

Katsuo Kojima

http://www.w3.org/2001/XMLSchema#string

Koshi Makita

http://www.w3.org/2001/XMLSchema#string

Madoka Shirasawa

http://www.w3.org/2001/XMLSchema#string

Tokujiro Uchida

http://www.w3.org/2001/XMLSchema#string

Yutaka Hata

http://www.w3.org/2001/XMLSchema#string

Zachary A. Matthay

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE)

Receptor for advanced glycation endproducts (RAGE) exhibits highly differential cellular and subcellular localisation in rat and human lung

A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study

The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination

cDNA cloning of a novel secreted isoform of the human receptor for advanced glycation end products and characterization of cells co-expressing cell-surface scavenger receptors and Swedish mutant amyloid precursor protein.

Identification of genes differentially expressed in rat alveolar type I cells.

Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.

Alveolar epithelial type I cells contain transport proteins and transport sodium, supporting an active role for type I cells in regulation of lung liquid homeostasis

P304

1008–1015

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4067732

http://www.w3.org/2001/XMLSchema#string

P356

10.1164/RCCM.200509-1477OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

173

http://www.w3.org/2001/XMLSchema#string

P50

Lorraine B. Ware

Michael Matthay

P577

2006-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16456142

http://www.w3.org/2001/XMLSchema#string

P932

2662912

http://www.w3.org/2001/XMLSchema#string